Saturday November 21 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Juvenile Rheumatoid Arthritis

Download PDF containing detailed information.PDF Version

Image Results

Loading...

Recent Publications on Juvenile Rheumatoid Arthritis:

Pubmed Logo
Rates of autoimmune diseases in Kaiser Permanente for use in vaccine adverse event safety studies.
Safety monitoring following new vaccine introduction includes assessment...
10th November, 2009
Kaiser Permanente Vaccine Study Center, Oakland, CA 94612, United States. Vaccine. 2009 Nov 4.
DOI Direct Link
High-dose daclizumab for the treatment of juvenile idiopathic arthritis-associated active anterior uveitis.
PURPOSE: To provide preliminary data regarding the safety and efficacy of...
6th November, 2009
National Eye Institute, Am J Ophthalmol. 2009 Nov;148(5):696-703.e1. Epub 2009 Aug 6.
DOI Direct Link
Potential predisposition for nasal septal perforation with methotrexate use: report of 2 cases and literature review.
Methotrexate is a dihydrofolate reductase inhibitor with application both...
30th October, 2009
Ear, Nose & Throat Center, Altru Health System, Grand Forks, ND 58201, Ear Nose Throat J. 2009 Aug;88(8):E12-4.
[Guidelines in RA treatment: concepts on safety and recommendations using anti-TNF-alpha inhibitors. Grupo de Estudio de Nuevas Terapias de Enfermedades reumaticas (GENTE)]
Recommendations for the use of Disease-Modifying Antirheumatic Drugs...
22nd October, 2009
Facultad de Medicina Universidad Nacional Autonoma de Mexico, Hospital Rev Invest Clin. 2009 May-Jun;61(3):252-66.
Hip arthrodesis in children: A review of 28 patients.
BACKGROUND: The best method of treating intractable hip pain in an...
20th October, 2009
Hospital and Rehabilitation Centre for Disabled Children (HRDC), Kathmandu Indian J Orthop. 2009 Oct;43(4):383-8.
DOI Direct Link

View more research publications.

Press Releases About Juvenile Rheumatoid Arthritis:

BioPortfolio Logo
Get Tested! KeyVive.com Encourages Americans to Answer the Question 'Do I Have Diabetes?' by Offering Free Blood Glucose Meters 18th November, 2009 KeyVive.com
PARK CITY, Utah, Nov. 18 /PRNewswire/ -- Did you know that 5.7 million people are unaware that they have diabetes? Symptoms can be as innocuous as excessive thirst and weight loss, frequent urination,
Arthritis Foundation Hosts Successful 'Commitment to a Cure' Awards Event to Fund Arthritis Research 17th November, 2009 Arthritis Foundation, Southern California Chapter
Actor Al Pacino and Gary N. Holland, M.D. Receive Prestigious Jane Wyman Humanitarian Award LOS ANGELES, Nov. 17 /PRNewswire-USNewswire/ -- The 22nd "Commitment to a Cure" Awards Gala
Diplomat Specialty Pharmacy Continues to Expand - Opens Location in Southern California 17th November, 2009 Diplomat Specialty Pharmacy
SWARTZ CREEK, Mich., Nov. 17 /PRNewswire/ -- Diplomat Specialty Pharmacy announced today the opening of their branch in San Bernardino, CA. Diplomat has 6 additional locations in Michigan, Ohio,
International Bullying Prevention Conference Explores Interventions, Effective Programs 16th November, 2009 International Bullying Prevention Association
PITTSBURGH, Nov. 16 /PRNewswire/ -- International experts, federal officials, school administrators, law enforcement, health care workers, parents and advocates will come together Tuesday, November 17
Hollis-Eden to Present Interim Data From Its Phase I/II Clinical Studies of Apoptone(R) (HE3235) at Molecular Targets and Cancer Therapeutics Conference 12th November, 2009 Hollis-Eden Pharmaceuticals, Inc.
SAN DIEGO, Nov. 12 /PRNewswire-FirstCall/ -- Hollis-Eden Pharmaceuticals, Inc. (Nasdaq: HEPH), will present results of its ongoing human clinical Phase I/II open-label dose-ranging trial with Apoptone

Juvenile Rheumatoid Arthritis Clinical Trials:

Clinical Trials Logo
Trial of Early Aggressive Drug Therapy in Juvenile Idiopathic Arthritis

Juvenile Rheumatoid Arthritis Patents:

USPTO Logo
US Patent No.Title
7553488 Antibodies against S100A8 and S100A9 proteins for modulating inflammatory reactions
7572446 Antagonists of HMG1 for treating inflammatory conditions
7576130 Dihydroxyl compounds and compositions for cholesterol management and related uses
7576182 Compositions and methods for the treatment of immune related diseases
7576222 Alkynyl-containing tryptophan derivative inhibitors of TACE/matrix metalloproteinase

View more patents.

Companies working in the area of Juvenile Rheumatoid Arthritis from Bioportfolio's Biocorporate database :

BioPortfolio Logo
Company Name

EnbrelŪ (etanercept)

EnbrelŪ (etanercept) is a TNF inhibitor approved for the following indications: moderately to severely active rheumatoid arthritis, polyarticular-course juvenile rheumatoid arthritis, psoriatic...
www.enbrel.com        View full profile
Thumbshot

Protein Therapeutics, Inc.

Protein Therapeutics, Inc. was founded in 1997 to discover and develop new therapies for chronic diseases.The initial focus of the company is to develop an oral formulation of human immunoglobulin ...
www.protein-therapeutics.com/        View full profile
Thumbshot

BioPortfolio Ltd. offers e-mail and postal lists for Juvenile Rheumatoid Arthritis scientists - we have details of around 719 individuals working on Juvenile Rheumatoid Arthritis .


This page has been viewed 894 times
Recent Search Terms used to find this page: guidelines in RA treatment concepts on safety and recommendation | juvenile rheumatoid arthritis pdf medicine | Juvenile Rheumatoid Arthritis pdf download | juvenile rheumatoid arthritis.pdf | juvenile rheumatoid arthritis wikipedia | 7547714 | rheumatoid arthritis pdf | juvenile rheumatoid arthritis pdf | juvenile idiopathic arthritis | .
Browse BioPortfolio's InDepth service - alphabetically: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z or by Most Publications, recently searched for, or most viewed.

Search for Juvenile Rheumatoid Arthritis across BioPortfolio, or for Juvenile Rheumatoid Arthritis Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH. Thumbshots from Thumbshots.org

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.